Abstract:Background To reduce cancer mortality and improve cancer outcomes, it is critical to understand the various cancer risk factors (RFs) across different domains (e.g., genetic, environmental, and behavioral risk factors) and levels (e.g., individual, interpersonal, and community levels). However, prior research on RFs of cancer outcomes, has primarily focused on individual level RFs due to the lack of integrated datasets that contain multi-level, multi-domain RFs. Further, the lack of a consensus and proper guidance on systematically identify RFs also increase the difficulty of RF selection from heterogenous data sources in a multi-level integrative data analysis (mIDA) study. More importantly, as mIDA studies require integrating heterogenous data sources, the data integration processes in the limited number of existing mIDA studies are inconsistently performed and poorly documented, and thus threatening transparency and reproducibility. Methods Informed by the National Institute on Minority Health and Health Disparities (NIMHD) research framework, we (1) reviewed existing reporting guidelines from the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) network and (2) developed a theory-driven reporting guideline to guide the RF variable selection, data source selection, and data integration process. Then, we developed an ontology to standardize the documentation of the RF selection and data integration process in mIDA studies. Results We summarized the review results and created a reporting guideline—ATTEST—for reporting the variable selection and data source selection and integration process. We provided an ATTEST check list to help researchers to annotate and clearly document each step of their mIDA studies to ensure the transparency and reproducibility. We used the ATTEST to report two mIDA case studies and further transformed annotation results into sematic triples, so that the relationships among variables, data sources and integration processes are explicitly standardized and modeled using the classes and properties from OD-ATTEST. Conclusion Our ontology-based reporting guideline solves some key challenges in current mIDA studies for cancer outcomes research, through providing (1) a theory-driven guidance for multi-level and multi-domain RF variable and data source selection; and (2) a standardized documentation of the data selection and integration processes powered by an ontology, thus a way to enable sharing of mIDA study reports among researchers. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This study was supported in part by the National Institute of Health (NIH) awards UL1TR001427 and R01CA246418 and Patient-Centered Outcomes Research Institute (PCORI) award ME-2018C3-14754. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or PCORI. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Our study doesn't require IRB approval. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes All the data needed are included in the manuscript. * ACS : American Cancer Society BRFSS : Behavioral Risk Factor Surveillance System EQUATOR : Enhancing the QUAlity and Transparency Of health Research FCDS : Florida Cancer Data System mIDA Multi-level Integrative Data Analysis NIH : National Institute of Health NIMHD : Minority Health and Health Disparities OD-ATTEST : Ontology for the Documentation of Variable and Data Source Selection and Integration Process RF : Risk Factor US : United States RUCA : Rural-Urban Commuting Area NCHS : National Center for Health Statistics BFO : Basic Formal Ontology NCBO : National Center for Biomedical Ontology RDF : Resource Description Framework GRIPS : Genetic RIsk Prediction Studies COHERE : Checklist for One Health Epidemiological Reporting of Evidence EHR Electronic Health Records OBI : Ontology for Biomedical Investigations IAO : Information Artifact Ontology NCIt : National Cancer Institute Thesaurus STATO : Statistics Ontology SIO : Semanticscience Integrated Ontology CDM : Common Data Model PCORnet : The national Patient-Centered Clinical Research Network

Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database

An Ontology-based Approach to Guide and Document Variable and Data Source Selection and Data Integration Process to Support Integrative Data Analysis in Cancer Outcomes Research

Standardised definitions and diagnostic criteria for extranodal extension detected on histopathological examination in head and neck cancer: Head and Neck Cancer International Group consensus recommendations

International recommendations for a vascular access minimum dataset: a Delphi consensus-building study

Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations

Development and Validation of Radiomic Signatures of Head and Neck Squamous Cell Carcinoma Molecular Features and Subtypes.

Abstract PO-010: Operationalizing the health care system electronic medical record to create head and neck cancer research and screening databases

Dataset for Reporting of Thymic Epithelial Tumours: Recommendations from the International Collaboration on Cancer Reporting (ICCR)

Data set for the reporting of lung cancer: recommendations from the International Collaboration on Cancer Reporting (ICCR)

HNCDB: an Integrated Gene and Drug Database for Head and Neck Cancer.

The 1+Million Genomes Minimal Dataset for Cancer

Development and external validation of a head and neck cancer risk prediction model

HeNeCOn: An ontology for integrative research in Head and Neck cancer

International Expert-Based Consensus Definition, Staging Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Inter-Disciplinary Modified Delphi Study

Consensus Recommendations for Management of Head and Neck Cancer in Asian Countries: A Review of International Guidelines

Cross-ancestral GWAS identifies 29 novel variants across Head and Neck Cancer subsites

Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: Head and Neck Cancer International Group consensus recommendations

Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure

Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCC

Supplementary Table 1 from Advancing Global Health Equity in Oncology Clinical Trial Access

Enabling cross-cultural data pooling in trials: linguistic validation of head and neck cancer measures for Indian patients